Circulating Tumor Cell News and Research

RSS
Transgenomic introduces ICE COLD-PCR mutation detection technology

Transgenomic introduces ICE COLD-PCR mutation detection technology

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

Fluxion Biosciences announces launch of Discovery Services business

Fluxion Biosciences announces launch of Discovery Services business

ScreenCell, Affymetrix partner to distribute CTC platform

ScreenCell, Affymetrix partner to distribute CTC platform

New microfluidic device can harvest rare circulating tumor cells from blood

New microfluidic device can harvest rare circulating tumor cells from blood

Scientists use two different methods to visualize rare CTCs, double positive cells in mBC

Scientists use two different methods to visualize rare CTCs, double positive cells in mBC

Lilly announces results of three preclinical studies that focus on c-MET receptor

Lilly announces results of three preclinical studies that focus on c-MET receptor

MD Anderson, Transgenomic partner to evaluate use of ICE COLD-PCR

MD Anderson, Transgenomic partner to evaluate use of ICE COLD-PCR

New microfluidic device can rapidly isolate target cells

New microfluidic device can rapidly isolate target cells

Positive updated results from Aeterna Zentaris' AEZS-108 Phase 1 trial on CRPC

Positive updated results from Aeterna Zentaris' AEZS-108 Phase 1 trial on CRPC

Researchers discover changes that cause tumor progression and metastasis

Researchers discover changes that cause tumor progression and metastasis

Patients having stray tumor cells in the blood should receive aggressive treatment

Patients having stray tumor cells in the blood should receive aggressive treatment

Dendrimers can capture circulating tumor cells in blood by biomimicry

Dendrimers can capture circulating tumor cells in blood by biomimicry

Transgenomic third quarter total revenue increases 87% to $8.3 million

Transgenomic third quarter total revenue increases 87% to $8.3 million

ScreenCell, Transgenomic sign collaboration and distribution agreement for CTC technology

ScreenCell, Transgenomic sign collaboration and distribution agreement for CTC technology

Simple low-cost method for isolation and collection of fragile prostate cancer cells

Simple low-cost method for isolation and collection of fragile prostate cancer cells

Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer

Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer

Encouraging data from Cylene CX-4945 Phase I dose-escalation trial presented at ASCO 2011

Encouraging data from Cylene CX-4945 Phase I dose-escalation trial presented at ASCO 2011